Display options
Share it on

Oncotarget. 2018 May 18;9(38):24950-24969. doi: 10.18632/oncotarget.25116. eCollection 2018 May 18.

Microglial SMAD4 regulated by microRNA-146a promotes migration of microglia which support tumor progression in a glioma environment.

Oncotarget

Aparna Karthikeyan, Neelima Gupta, Carol Tang, Karthik Mallilankaraman, Maskomani Silambarasan, Meng Shi, Lei Lu, Beng Ti Ang, Eng-Ang Ling, S Thameem Dheen

Affiliations

  1. Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  2. Department of Research, National Neuroscience Institute, Singapore.
  3. Duke-NUS Medical School, Singapore.
  4. Division of Cellular and Molecular Research, National Cancer Centre, Singapore.
  5. Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  6. School of Biological Sciences, Nanyang Technological University, Singapore.
  7. Department of Neurosurgery, National Neuroscience Institute, Singapore.
  8. Singapore Institute for Clinical Sciences, ASTAR, Singapore.

PMID: 29861845 PMCID: PMC5982777 DOI: 10.18632/oncotarget.25116

Abstract

Glioma tumors constitute a significant portion of microglial cells, which are known to support tumor progression. The present study demonstrates that transforming growth factor-β (TGFβ) signaling pathway in microglia in a glioma environment is involved in tumor progression and pathogenesis. It has been shown that the TGFβ level is elevated in higher grades of gliomas and its signaling pathway regulates tumor progression through phosphorylation of SMAD2 and SMAD3, which form a complex with SMAD4 to regulate target gene transcription. In an

Keywords: SMAD4; TGFβ; glioma; microRNA-146a; microglia

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare no conflicts of interest.

References

  1. Cell Death Dis. 2016 Apr 07;7:e2174 - PubMed
  2. PLoS One. 2012;7(2):e30832 - PubMed
  3. Acta Neuropathol. 1996 Sep;92(3):288-93 - PubMed
  4. Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6 - PubMed
  5. Cancer Cell. 2007 Feb;11(2):147-60 - PubMed
  6. Cell. 2013 Dec 19;155(7):1596-609 - PubMed
  7. Mol Carcinog. 2016 Dec;55(12 ):2247-2259 - PubMed
  8. Cancer Cell. 2014 May 12;25(5):666-81 - PubMed
  9. Science. 2011 Sep 9;333(6048):1456-8 - PubMed
  10. Genes Dev. 2005 Dec 1;19(23):2783-810 - PubMed
  11. Oncogene. 2015 Sep 24;34(39):5055-68 - PubMed
  12. Clin Cancer Res. 2013 Jul 15;19(14):3776-86 - PubMed
  13. Nat Med. 2012 Feb 19;18(3):429-35 - PubMed
  14. Glia. 2013 Jul;61(7):1178-90 - PubMed
  15. PLoS One. 2012;7(9):e44789 - PubMed
  16. PLoS One. 2015 Apr 13;10(4):e0123553 - PubMed
  17. J Neurotrauma. 2016 Oct 1;33(19):1732-1750 - PubMed
  18. BMC Dev Biol. 2009 Oct 22;9:54 - PubMed
  19. Methods. 2001 Dec;25(4):402-8 - PubMed
  20. Science. 2002 May 31;296(5573):1646-7 - PubMed
  21. J Neuropathol Exp Neurol. 2017 Sep 1;76(9):736-753 - PubMed
  22. Glia. 2014 Jun;62(6):881-95 - PubMed
  23. Eur J Cancer. 2010 Dec;46(18):3383-92 - PubMed
  24. Genes Dev. 2006 Nov 15;20(22):3130-46 - PubMed
  25. Mol Neurobiol. 2017 Oct;54(8):6391-6411 - PubMed
  26. Curr Med Chem. 2007;14(11):1189-97 - PubMed
  27. Glia. 2011 Mar;59(3):472-85 - PubMed
  28. Nat Cell Biol. 2012 Dec;14(12):1336-43 - PubMed
  29. Front Immunol. 2014 Nov 21;5:578 - PubMed
  30. J Neuroimmunol. 2007 Oct;190(1-2):53-60 - PubMed
  31. Neoplasia. 2004 Jan-Feb;6(1):1-6 - PubMed
  32. Cell Mol Neurobiol. 2016 Jul;36(5):777-88 - PubMed
  33. Glia. 2016 Dec;64(12 ):2079-2092 - PubMed
  34. Curr Med Chem. 2016;23 (30):3528-3546 - PubMed
  35. Eur J Neurosci. 1997 Aug;9(8):1690-8 - PubMed
  36. Mol Endocrinol. 2015 Oct;29(10 ):1440-53 - PubMed
  37. Nat Neurosci. 2013 Sep;16(9):1211-1218 - PubMed
  38. J Biol Chem. 2013 Nov 1;288(44):31488-95 - PubMed
  39. Neuron. 2012 May 24;74(4):691-705 - PubMed
  40. JCI Insight. 2016;1(2): - PubMed
  41. Mol Cell Biol. 2011 Sep;31(17):3584-92 - PubMed
  42. Carcinogenesis. 2013 Feb;34(2):331-40 - PubMed
  43. J Neurosci Res. 2012 Oct;90(10):1970-80 - PubMed
  44. PLoS One. 2015 Feb 06;10(2):e0116644 - PubMed
  45. Oncogene. 2008 Feb 7;27(7):918-30 - PubMed
  46. J Biol Chem. 2008 Feb 1;283(5):2526-33 - PubMed
  47. Mol Neurobiol. 2016 Mar;53(2):1181-94 - PubMed
  48. J Neurochem. 2014 Aug;130(3):388-401 - PubMed
  49. Arch Virol. 2017 Jun;162(6):1495-1505 - PubMed
  50. Glia. 2013 Feb;61(2):287-300 - PubMed
  51. Biochem Pharmacol. 2013 Feb 15;85(4):478-85 - PubMed
  52. Mol Cell Biol. 2005 Sep;25(18):8108-25 - PubMed
  53. Front Neurol. 2014 Sep 29;5:181 - PubMed
  54. Nat Immunol. 2016 Nov;17 (11):1282-1290 - PubMed
  55. Glia. 2002 Nov;40(2):252-9 - PubMed
  56. J Immunol. 2004 Jul 15;173(2):962-8 - PubMed
  57. BMC Cancer. 2016 Feb 08;16:72 - PubMed
  58. Neurosci Lett. 2014 Nov 7;583:130-5 - PubMed
  59. Cancer Lett. 2013 Jul 10;335(1):201-4 - PubMed
  60. J Biol Chem. 2008 Nov 14;283(46):31315-22 - PubMed
  61. J Immunol. 1993 Aug 15;151(4):2150-8 - PubMed
  62. Cancer Cell. 2010 Jan 19;17(1):98-110 - PubMed
  63. Cell Stem Cell. 2015 Mar 5;16(3):219-20 - PubMed
  64. Neurochem Res. 2014 Feb;39(2):233-43 - PubMed
  65. Nat Neurosci. 2016 Jan;19(1):20-7 - PubMed

Publication Types